* Health and Medical News:Cellectis jumps 14% on talks of sale to Pfizer

Pfizer reportedly approached Cellectis with a deal that could value it at about $1.64 billion, the Financial Times reported.

from @ Health and Medical News http://ift.tt/1G4fbQF
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...

Popular Health News